Literature DB >> 9499125

Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP.

R Tomazin1, N E van Schoot, K Goldsmith, P Jugovic, P Sempé, K Früh, D C Johnson.   

Abstract

Herpes simplex virus serotype 1 (HSV-1) expresses an immediate-early protein, ICP47, that effectively blocks the major histocompatibility complex class I antigen presentation pathway. HSV-1 ICP47 (ICP47-1) binds with high affinity to the human transporter associated with antigen presentation (TAP) and blocks the binding of antigenic peptides. HSV type 2 (HSV-2) ICP47 (ICP47-2) has only 42% amino acid sequence identity with ICP47-1. Here, we compared the levels of inhibition of human and murine TAP, expressed in insect cell microsomes, by ICP47-1 and ICP47-2. Both proteins inhibited human TAP at similar concentrations, and the K(D) for ICP47-2 binding to human TAP was 4.8 x 10(-8) M, virtually identical to that measured for ICP47-1 (5.2 x 10(-8) M). There was some inhibition of murine TAP by both ICP47-2 and ICP47-1, but this inhibition was incomplete and only at ICP47 concentrations 50 to 100 times that required to inhibit human TAP. Lack of inhibition of murine TAP by ICP47-1 and ICP47-2 could be explained by an inability of both proteins to bind to murine TAP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499125      PMCID: PMC109564          DOI: 10.1128/JVI.72.3.2560-2563.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.

Authors:  R Tomazin; A B Hill; P Jugovic; I York; P van Endert; H L Ploegh; D W Andrews; D C Johnson
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

2.  Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; D H Brauer
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

3.  A viral inhibitor of peptide transporters for antigen presentation.

Authors:  K Früh; K Ahn; H Djaballah; P Sempé; P M van Endert; R Tampé; P A Peterson; Y Yang
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

4.  A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

Authors:  I A York; C Roop; D W Andrews; S R Riddell; F L Graham; D C Johnson
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

5.  A sequential model for peptide binding and transport by the transporters associated with antigen processing.

Authors:  P M van Endert; R Tampé; T H Meyer; R Tisch; J F Bach; H O McDevitt
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

6.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Authors:  K Ahn; T H Meyer; S Uebel; P Sempé; H Djaballah; Y Yang; P A Peterson; K Früh; R Tampé
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

7.  Herpes simplex virus turns off the TAP to evade host immunity.

Authors:  A Hill; P Jugovic; I York; G Russ; J Bennink; J Yewdell; H Ploegh; D Johnson
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

8.  Peptide translocation by variants of the transporter associated with antigen processing.

Authors:  M T Heemels; T N Schumacher; K Wonigeit; H L Ploegh
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

9.  The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues.

Authors:  B Galocha; A Hill; B C Barnett; A Dolan; A Raimondi; R F Cook; J Brunner; D J McGeoch; H L Ploegh
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.

Authors:  K Goldsmith; W Chen; D C Johnson; R L Hendricks
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

  10 in total
  52 in total

1.  Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

Authors:  T Todo; R L Martuza; S D Rabkin; P A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 2.  Viral evasion of the MHC class I antigen-processing machinery.

Authors:  Sandra Loch; Robert Tampé
Journal:  Pflugers Arch       Date:  2005-08-06       Impact factor: 3.657

3.  Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.

Authors:  Michael T Hensel; Tao Peng; Anqi Cheng; Stephen C De Rosa; Anna Wald; Kerry J Laing; Lichen Jing; Lichun Dong; Amalia S Magaret; David M Koelle
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.

Authors:  Francisco J Branco; Nigel W Fraser
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

6.  Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro.

Authors:  C A Jones; M Fernandez; K Herc; L Bosnjak; M Miranda-Saksena; R A Boadle; A Cunningham
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis.

Authors:  Anibal G Armien; Shuxian Hu; Morgan R Little; Nicholas Robinson; James R Lokensgard; Walter C Low; Maxim C-J Cheeran
Journal:  Brain Pathol       Date:  2009-11-05       Impact factor: 6.508

8.  In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Authors:  T Nagashunmugam; J Lubinski; L Wang; L T Goldstein; B S Weeks; P Sundaresan; E H Kang; G Dubin; H M Friedman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Identification of an ICP47 homologue in simian agent 8 (SA8).

Authors:  John E Bigger; David W Martin
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

10.  An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.

Authors:  A X Holterman; K Rogers; K Edelmann; D M Koelle; L Corey; C B Wilson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.